1 / 12

Revolutionizing pharmaceutical development

Revolutionizing pharmaceutical development. by Lilien Cheminformatics University of Toronto, December 2009 S ynPlan@gmail.com. University of Toronto, December 2009 . Chemists use pen & paper to generate reaction plans for target molecule .

raisie
Download Presentation

Revolutionizing pharmaceutical development

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Revolutionizing pharmaceutical development by LilienCheminformatics University of Toronto, December 2009 SynPlan@gmail.com

  2. University of Toronto, December 2009 Chemists use pen & paper to generate reaction plans for target molecule. ...over 100 million chemical substances and sequences! 2

  3. The Solution University of Toronto, December 2009 • Automate Planning • Reduce scale-up time from 2 yrs to 2 months • Extended patent protection • Discover new reaction pathways. 3

  4. Business Model Canvas Infrastructure Customer Finance Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 University of Toronto, December 2009

  5. Business Model Canvas Infrastructure Customer Partner Network Key Activities R&D Academia Education & Training Reaction DB Key Resources Publishing Companies Experts in chemistry & technology. Finance Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 4 University of Toronto, December 2009

  6. Business Model Canvas Infrastructure Customer Partner Network Key Activities Pharmaceutical companies R&D Academia Distribution Channel Education & Training Reaction DB Networking within Universities Website with cd/dvds of products Key Resources Publishing Companies Experts in chemistry & technology. Reaction DB updates Training, Support Finance Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 4 University of Toronto, December 2009

  7. Business Model Canvas Infrastructure Customer Partner Network Key Activities Pharmaceutical companies R&D Academia Distribution Channel Education & Training Reaction DB Networking within Universities Website with cd/dvds of products Key Resources Publishing Companies Experts in chemistry & technology. Reaction DB updates Training, Support Finance Cost Structure Revenue Streams Maintenance R&D Yearly Licensing Model Support Staff Marketing Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 4 University of Toronto, December 2009

  8. Competition Efficiency ARChem Theresa LHASA SynChem Completeness University of Toronto, December 2009

  9. The Magic • Expertise • Over 10 years of research • Partners • Close relations industry contacts • Opportunity • Increasing cost • Decreased drug approval University of Toronto, December 2009

  10. The Team • Peter Park, CEO • Brian Keng, CFO • DejanaBajic, VP Sales and Marketing • Maryah Safi, VP Product Development • Amanda Manarin, Sales and Finance University of Toronto, December 2009

  11. University of Toronto, December 2009 TotalOperatingCosts TotalRevenue Net Earnings 8

  12. How you can help • Invest $1.2 million: • Alpha release of product • Covers cash flow for first year • Establish contacts with phamas University of Toronto, December 2009

More Related